The U.S. Drug Enforcement Administration and the Department of Health and Human Services will delay the effective date of two final rules that were expected to go into effect on Friday, March 21. By extending…
Continue Reading
The U.S. Drug Enforcement Administration has proposed draft guidance to establish a framework for prescribing controlled substances via telemedicine.The proposal introduces three types of special registrations. Telemedicine prescribing registration allows qualified practitioners to prescribe…
Continue Reading
With less than three months before the clock runs out on telemedicine electronic prescribing flexibilities, Reps. Doris Matsui, D-California, and Earl “Buddy” Carter, R-Georgia, are leading a bipartisan charge to urge the U.S. Drug…
Continue Reading
With current pandemic-era flexibilities for telemedicine set to expire at the end of 2024, several telehealth groups and major health systems are calling on the U.S. Drug Enforcement Administration to work faster in crafting…
Continue Reading
The U.S. Drug Enforcement Administration’s stance on prescribing via telehealth has been evolving, with hints toward an appetite for lasting flexibilities. This, among other policy shifts, has a direct impact on healthcare provider organizations…
Continue Reading
After the Drug Enforcement Administration (DEA) announced Wednesday that it is temporarily extending Covid-19 flexibilities for the prescribing of controlled substances via telemedicine, several telehealth advocates came out in support of the decision.
These flexibilities…
